{"product_id":"color-atlas-of-the-horse-8217-s-foot-pdf","title":"Color Atlas of the Horse's Foot","description":"\u003ch2\u003eColor Atlas of the Horse's Foot\u003c\/h2\u003e\u003cp\u003e\u003cstrong\u003eProfessional Veterinary E-Book - Instant PDF Download\u003c\/strong\u003e\u003c\/p\u003e\u003cp\u003eComprehensive veterinary reference covering color atlas of the horse's foot. This digital edition provides in-depth coverage suitable for veterinarians, veterinary students, technicians, and animal health professionals.\u003c\/p\u003e\u003cp\u003e\u003cstrong\u003eKey Features:\u003c\/strong\u003e\u003c\/p\u003e\u003cul\u003e\n\u003cli\u003eInstant digital download after purchase\u003c\/li\u003e\n\u003cli\u003eHigh-quality PDF format - works on all devices\u003c\/li\u003e\n\u003cli\u003eFully searchable text for quick clinical reference\u003c\/li\u003e\n\u003cli\u003ePrintable pages for study and practice use\u003c\/li\u003e\n\u003c\/ul\u003e\u003cp\u003e\u003cstrong\u003eCategory:\u003c\/strong\u003e Veterinary Medicine\u003c\/p\u003e\u003cp\u003e\u003cem\u003ePublished by Global Vet and Co Ltd.\u003c\/em\u003e\u003c\/p\u003e\n\n\u003ch3\u003eTable of Contents\u003c\/h3\u003e\n\u003cdiv class=\"gvc-locked-preview\"\u003e\n  \u003cdiv class=\"gvc-locked-icon\"\u003e🔒\u003c\/div\u003e\n  \u003ch3\u003eSample Preview\u003c\/h3\u003e\n  \u003cp\u003eThe full PDF is available after purchase. Instant download. Lifetime access. Read on any device.\u003c\/p\u003e\n  \u003cp class=\"gvc-locked-meta\"\u003eTrusted by 4,000+ veterinary professionals worldwide.\u003c\/p\u003e\n\u003c\/div\u003e\n\n\u003cul\u003e\n  \u003cli\u003ePreface (p.11)\u003c\/li\u003e\n  \u003cli\u003e1 Introduction (p.15)\u003c\/li\u003e\n  \u003cli\u003e2 Introduction to First Edition (p.17)\u003c\/li\u003e\n  \u003cli\u003e3 The History of the Rat (p.21)\u003c\/li\u003e\n  \u003cli\u003e1 Introduction (p.21)\u003c\/li\u003e\n  \u003cli\u003e2 Origin (p.21)\u003c\/li\u003e\n  \u003cli\u003e3 Use of the Rat Strains in Chronic Carcinogenicity Studies (p.23)\u003c\/li\u003e\n  \u003cli\u003e4 Comparison of the Rat Strains for Early Onset of Neoplasms (p.25)\u003c\/li\u003e\n  \u003cli\u003e4 Oral Cavity, Teeth and Gingiva (p.27)\u003c\/li\u003e\n  \u003cli\u003e1 Normal Oral Cavity (p.27)\u003c\/li\u003e\n  \u003cli\u003e2 Congenital Anomalies (p.28)\u003c\/li\u003e\n  \u003cli\u003e3 Degenerative Lesions (p.29)\u003c\/li\u003e\n  \u003cli\u003e4 Inflammatory and Vascular Lesions (p.29)\u003c\/li\u003e\n  \u003cli\u003e5 Hyperplastic and Neoplastic Lesions (p.29)\u003c\/li\u003e\n  \u003cli\u003e6 Toxicologic Lesions (p.30)\u003c\/li\u003e\n  \u003cli\u003e5 Salivary Glands (p.35)\u003c\/li\u003e\n  \u003cli\u003e1 Introduction (p.35)\u003c\/li\u003e\n  \u003cli\u003e2 Normal Salivary Glands (p.35)\u003c\/li\u003e\n  \u003cli\u003e3 Congenital Lesions (p.38)\u003c\/li\u003e\n  \u003cli\u003e4 Degenerative Lesions (p.38)\u003c\/li\u003e\n  \u003cli\u003e5 Inflammatory and Vascular Lesions (p.40)\u003c\/li\u003e\n  \u003cli\u003e6 Hyperplastic and Neoplastic Lesions (p.40)\u003c\/li\u003e\n  \u003cli\u003e7 Toxicologic Lesions (p.44)\u003c\/li\u003e\n  \u003cli\u003e6 Esophagus and Stomach (p.47)\u003c\/li\u003e\n  \u003cli\u003e1 Introduction (p.47)\u003c\/li\u003e\n  \u003cli\u003e2 Normal Upper Digestive Tract (p.47)\u003c\/li\u003e\n  \u003cli\u003e3 Congenital Anomalies (p.50)\u003c\/li\u003e\n  \u003cli\u003e4 Degenerative Lesions (p.51)\u003c\/li\u003e\n  \u003cli\u003e5 Inflammatory and Vascular Lesions (p.52)\u003c\/li\u003e\n  \u003cli\u003e6 Hyperplastic and Neoplastic Lesions (p.53)\u003c\/li\u003e\n  \u003cli\u003e7 Miscellaneous Lesions (p.58)\u003c\/li\u003e\n  \u003cli\u003e8 Toxicologic Lesions (p.58)\u003c\/li\u003e\n  \u003cli\u003e7 Small and Large Intestine (p.63)\u003c\/li\u003e\n  \u003cli\u003e1 Introduction (p.63)\u003c\/li\u003e\n  \u003cli\u003e2 Normal Intestine (p.63)\u003c\/li\u003e\n  \u003cli\u003e3 Congenital Anomalies (p.67)\u003c\/li\u003e\n  \u003cli\u003e4 Degenerative Lesions (p.67)\u003c\/li\u003e\n  \u003cli\u003e5 Inflammatory and Vascular Lesions (p.68)\u003c\/li\u003e\n  \u003cli\u003e6 Hyperplastic and Neoplastic Lesions (p.69)\u003c\/li\u003e\n  \u003cli\u003e7 Miscellaneous Lesions (p.75)\u003c\/li\u003e\n  \u003cli\u003e8 Toxicologic Lesions (p.76)\u003c\/li\u003e\n  \u003cli\u003e8 Peritoneum, Retroperitoneum, Mesentery, and Abdominal Cavity (p.83)\u003c\/li\u003e\n  \u003cli\u003e1 Introduction (p.83)\u003c\/li\u003e\n  \u003cli\u003e2 Normal Peritoneum (p.83)\u003c\/li\u003e\n  \u003cli\u003e3 Congenital Anomalies (p.84)\u003c\/li\u003e\n  \u003cli\u003e4 Degenerative Lesions (p.84)\u003c\/li\u003e\n  \u003cli\u003e5 Inflammatory and Vascular Lesions (p.85)\u003c\/li\u003e\n  \u003cli\u003e6 Hyperplastic and Neoplastic Lesions (p.85)\u003c\/li\u003e\n  \u003cli\u003e7 Miscellaneous Lesions (p.88)\u003c\/li\u003e\n  \u003cli\u003e8 Toxicologic Lesions (p.88)\u003c\/li\u003e\n  \u003cli\u003e9 Liver (p.91)\u003c\/li\u003e\n  \u003cli\u003e1 Introduction (p.91)\u003c\/li\u003e\n  \u003cli\u003e2 Normal Liver (p.91)\u003c\/li\u003e\n  \u003cli\u003e3 Congenital Lesions (p.95)\u003c\/li\u003e\n  \u003cli\u003e4 Degenerative Lesions (p.96)\u003c\/li\u003e\n  \u003cli\u003e5 Inflammatory and Vascular Lesions (p.99)\u003c\/li\u003e\n  \u003cli\u003e6 Hyperplastic and Neoplastic Lesions (p.101)\u003c\/li\u003e\n  \u003cli\u003e7 Miscellaneous Lesions (p.111)\u003c\/li\u003e\n  \u003cli\u003e10 Exocrine Pancreas (p.117)\u003c\/li\u003e\n  \u003cli\u003e11 Kidney (p.133)\u003c\/li\u003e\n  \u003cli\u003e1 Introduction (p.133)\u003c\/li\u003e\n  \u003cli\u003e2 Normal Kidney (p.134)\u003c\/li\u003e\n  \u003cli\u003e3 Congenital Lesions (p.142)\u003c\/li\u003e\n  \u003cli\u003e4 Degenerative Lesions (p.143)\u003c\/li\u003e\n  \u003cli\u003e5 Inflammatory and Vascular Lesions (p.149)\u003c\/li\u003e\n  \u003cli\u003e6 Hyperplastic and Neoplastic Lesions (p.152)\u003c\/li\u003e\n  \u003cli\u003e7 Miscellaneous Changes (p.163)\u003c\/li\u003e\n  \u003cli\u003e8 Artifacts (p.163)\u003c\/li\u003e\n  \u003cli\u003e9 Toxicologic Lesions (p.164)\u003c\/li\u003e\n  \u003cli\u003e12 Urinary Bladder, Ureter, and Urethra (p.175)\u003c\/li\u003e\n  \u003cli\u003e1 Introduction (p.175)\u003c\/li\u003e\n  \u003cli\u003e2 Normal Urinary Pathway (p.175)\u003c\/li\u003e\n  \u003cli\u003e3 Congenital Lesions (p.180)\u003c\/li\u003e\n  \u003cli\u003e4 Inflammatory Lesions (p.180)\u003c\/li\u003e\n  \u003cli\u003e5 Hyperplastic and Neoplastic Lesions (p.181)\u003c\/li\u003e\n  \u003cli\u003e6 Miscellaneous (p.190)\u003c\/li\u003e\n  \u003cli\u003e7 Toxicologic Lesions (p.193)\u003c\/li\u003e\n  \u003cli\u003e8 Experimentally Induced URINARY BLADDER Carcinogenesis (p.193)\u003c\/li\u003e\n  \u003cli\u003e13 Brain (p.197)\u003c\/li\u003e\n  \u003cli\u003e1 Introduction (p.197)\u003c\/li\u003e\n  \u003cli\u003e2 Congenital Lesions (p.204)\u003c\/li\u003e\n  \u003cli\u003e3 Degenerative Lesions (p.204)\u003c\/li\u003e\n  \u003cli\u003e4 Hyperplastic Lesions (p.209)\u003c\/li\u003e\n  \u003cli\u003e5 Neoplastic Lesions (p.210)\u003c\/li\u003e\n  \u003cli\u003e6 Toxicologic Lesions (p.217)\u003c\/li\u003e\n  \u003cli\u003e14 The Spinal Cord and Peripheral Nervous System (p.223)\u003c\/li\u003e\n  \u003cli\u003e1 Spinal Cord and Peripheral Nerves (p.223)\u003c\/li\u003e\n  \u003cli\u003e2 Artifacts (p.235)\u003c\/li\u003e\n  \u003cli\u003e3 Toxicologic Lesions (p.237)\u003c\/li\u003e\n  \u003cli\u003e4 Animal Models of Peripheral Neuropathies (p.241)\u003c\/li\u003e\n  \u003cli\u003eReferences (p.242)\u003c\/li\u003e\n  \u003cli\u003e15 Ears and Pinna (p.247)\u003c\/li\u003e\n  \u003cli\u003e1 Introduction (p.247)\u003c\/li\u003e\n  \u003cli\u003e2 Normal Ear and Pinna (p.247)\u003c\/li\u003e\n  \u003cli\u003e3 Congenital Lesions (p.250)\u003c\/li\u003e\n  \u003cli\u003e4 Degenerative Lesions (p.250)\u003c\/li\u003e\n  \u003cli\u003e5 Inflammatory and Vascular Lesions (p.250)\u003c\/li\u003e\n  \u003cli\u003e6 Hyperplastic and Neoplastic Lesions (p.252)\u003c\/li\u003e\n  \u003cli\u003e7 Neural Crest Neoplasm of the Pinna (p.253)\u003c\/li\u003e\n  \u003cli\u003e8 Miscellaneous Lesions (p.254)\u003c\/li\u003e\n  \u003cli\u003e9 Toxicologic Lesions (p.254)\u003c\/li\u003e\n  \u003cli\u003e16 Eye and Associated Glands (p.257)\u003c\/li\u003e\n  \u003cli\u003e1 Introduction (p.258)\u003c\/li\u003e\n  \u003cli\u003e2 Normal Eye and Associated Glands (p.258)\u003c\/li\u003e\n  \u003cli\u003e3 Congenital Lesions (p.266)\u003c\/li\u003e\n  \u003cli\u003e4 Degenerative Lesions (p.267)\u003c\/li\u003e\n  \u003cli\u003e5 Inflammatory and Vascular Lesions (p.272)\u003c\/li\u003e\n  \u003cli\u003e6 Hyperplastic and Neoplastic Lesions (p.273)\u003c\/li\u003e\n  \u003cli\u003e7 Miscellaneous Lesions (p.277)\u003c\/li\u003e\n  \u003cli\u003e8 Toxicologic Lesions (p.278)\u003c\/li\u003e\n  \u003cli\u003e17 Skeletal Muscle (p.285)\u003c\/li\u003e\n  \u003cli\u003e1 Introduction (p.285)\u003c\/li\u003e\n  \u003cli\u003e2 Normal Skeletal Muscle (p.285)\u003c\/li\u003e\n  \u003cli\u003e3 Congenital Anomalies (p.289)\u003c\/li\u003e\n  \u003cli\u003e4 Degenerative Lesions (p.289)\u003c\/li\u003e\n  \u003cli\u003e5 Parasitic, Inflammatory, and Vascular Lesions (p.292)\u003c\/li\u003e\n  \u003cli\u003e6 Hyperplastic and Neoplastic Lesions (p.292)\u003c\/li\u003e\n  \u003cli\u003e7 Miscellaneous (p.293)\u003c\/li\u003e\n  \u003cli\u003e8 Toxicologic Lesions (p.294)\u003c\/li\u003e\n  \u003cli\u003e18 Bones, Joints, and Synovia (p.303)\u003c\/li\u003e\n  \u003cli\u003e1 Introduction (p.303)\u003c\/li\u003e\n  \u003cli\u003e2 Normal Bones, Joints, and Synovia (p.303)\u003c\/li\u003e\n  \u003cli\u003e3 Non-proliferative Lesions (p.308)\u003c\/li\u003e\n  \u003cli\u003e4 Hyperplastic and Neoplastic Lesions (p.315)\u003c\/li\u003e\n  \u003cli\u003e19 The Skin and Subcutis (p.325)\u003c\/li\u003e\n  \u003cli\u003e1 Introduction (p.325)\u003c\/li\u003e\n  \u003cli\u003e2 Normal Skin and Subcutis (p.326)\u003c\/li\u003e\n  \u003cli\u003e3 Infectious Diseases (p.329)\u003c\/li\u003e\n  \u003cli\u003e4 Congenital Lesions (p.329)\u003c\/li\u003e\n  \u003cli\u003e5 Non-neoplastic Lesions (p.329)\u003c\/li\u003e\n  \u003cli\u003e6 Hyperplastic and Neoplastic Lesions (p.333)\u003c\/li\u003e\n  \u003cli\u003e7 Toxicologic Lesions (p.343)\u003c\/li\u003e\n  \u003cli\u003e20 Specialized Sebaceous Glands—Zymbal’s Gland, Preputial Gland, Clitoral Gland, and Perianal Gland (p.349)\u003c\/li\u003e\n  \u003cli\u003e1 Introduction (p.349)\u003c\/li\u003e\n  \u003cli\u003e2 Normal Specialized Sebaceous Gland (p.349)\u003c\/li\u003e\n  \u003cli\u003e3 Congenital Lesions (p.353)\u003c\/li\u003e\n  \u003cli\u003e4 Degenerative Lesions (p.353)\u003c\/li\u003e\n  \u003cli\u003e5 Inflammatory Lesions (p.354)\u003c\/li\u003e\n  \u003cli\u003e6 Growth Disturbances (Non-Neoplastic) (p.354)\u003c\/li\u003e\n  \u003cli\u003e7 Growth Disturbances (Neoplastic) (p.356)\u003c\/li\u003e\n  \u003cli\u003e8 Toxicologic Lesions (p.361)\u003c\/li\u003e\n  \u003cli\u003e21 Mammary Gland (p.369)\u003c\/li\u003e\n  \u003cli\u003e1 Introduction (p.369)\u003c\/li\u003e\n  \u003cli\u003e2 Normal Mammary Gland (p.369)\u003c\/li\u003e\n  \u003cli\u003e3 Congenital Lesions (p.372)\u003c\/li\u003e\n  \u003cli\u003e4 Degenerative Lesions (p.372)\u003c\/li\u003e\n  \u003cli\u003e5 Inflammatory and Vascular Lesions (p.374)\u003c\/li\u003e\n  \u003cli\u003e6 Hyperplastic and Neoplastic Lesions (p.374)\u003c\/li\u003e\n  \u003cli\u003e7 Miscellaneous Lesions (p.382)\u003c\/li\u003e\n  \u003cli\u003e8 Toxicologic Lesions (p.383)\u003c\/li\u003e\n  \u003cli\u003e22 Nose, Larynx, and Trachea (p.389)\u003c\/li\u003e\n  \u003cli\u003e1 Introduction (p.389)\u003c\/li\u003e\n  \u003cli\u003e2 Normal Upper Respiratory Tract (p.390)\u003c\/li\u003e\n  \u003cli\u003e3 Congenital Lesions (p.400)\u003c\/li\u003e\n  \u003cli\u003e4 Degenerative, Regenerative, and Adaptive Lesions (p.400)\u003c\/li\u003e\n  \u003cli\u003e5 Inflammatory and Vascular Lesions (p.409)\u003c\/li\u003e\n  \u003cli\u003e6 Hyperplastic and Neoplastic Lesions (p.413)\u003c\/li\u003e\n  \u003cli\u003e7 Miscellaneous (p.424)\u003c\/li\u003e\n  \u003cli\u003e8 Toxicologic Lesions (p.426)\u003c\/li\u003e\n  \u003cli\u003e9 Molecular Pathology of the Upper Respiratory Tract (p.429)\u003c\/li\u003e\n  \u003cli\u003eReferences (p.431)\u003c\/li\u003e\n  \u003cli\u003e23 Lung, Pleura, and Mediastinum (p.435)\u003c\/li\u003e\n  \u003cli\u003e1 Introduction (p.435)\u003c\/li\u003e\n  \u003cli\u003e2 Normal Lung (p.436)\u003c\/li\u003e\n  \u003cli\u003e3 Congenital Lesions (p.441)\u003c\/li\u003e\n  \u003cli\u003e4 Infectious Diseases (p.442)\u003c\/li\u003e\n  \u003cli\u003e5 Nonproliferative, Degenerative, and Vascular Lesions (p.444)\u003c\/li\u003e\n  \u003cli\u003e6 Nonneoplastic and Neoplastic Proliferative Lesions (p.446)\u003c\/li\u003e\n  \u003cli\u003e7 Miscellaneous Lesions (p.457)\u003c\/li\u003e\n  \u003cli\u003e8 Toxicologic Lesions (p.458)\u003c\/li\u003e\n  \u003cli\u003eReferences (p.461)\u003c\/li\u003e\n  \u003cli\u003e24 Spleen, Lymph Nodes, and Thymus (p.465)\u003c\/li\u003e\n  \u003cli\u003e1 Spleen (p.466)\u003c\/li\u003e\n  \u003cli\u003e2 Normal Spleen (p.466)\u003c\/li\u003e\n  \u003cli\u003e3 Anatomy and Histology (p.466)\u003c\/li\u003e\n  \u003cli\u003e4 Function (p.467)\u003c\/li\u003e\n  \u003cli\u003e5 Congenital Lesions (p.468)\u003c\/li\u003e\n  \u003cli\u003e6 Degenerative Lesions (p.468)\u003c\/li\u003e\n  \u003cli\u003e7 Inflammatory and Vascular Lesions (p.469)\u003c\/li\u003e\n  \u003cli\u003e8 Hyperplastic and Neoplastic Lesions (p.470)\u003c\/li\u003e\n  \u003cli\u003e9 Neoplasia (p.471)\u003c\/li\u003e\n  \u003cli\u003e10 Lymphoma and Other Hematopoietic Neoplasms (p.473)\u003c\/li\u003e\n  \u003cli\u003e11 Mesenchymal Neoplasms (p.473)\u003c\/li\u003e\n  \u003cli\u003e12 Other Neoplasms (p.475)\u003c\/li\u003e\n  \u003cli\u003e13 Miscellaneous (p.476)\u003c\/li\u003e\n  \u003cli\u003e14 Toxicologic Lesions (p.476)\u003c\/li\u003e\n  \u003cli\u003e15 Lymph Nodes (p.476)\u003c\/li\u003e\n  \u003cli\u003e16 Normal Lymph Nodes (p.477)\u003c\/li\u003e\n  \u003cli\u003e17 Congenital Lesions (p.478)\u003c\/li\u003e\n  \u003cli\u003e18 Degenerative Lesions (p.478)\u003c\/li\u003e\n  \u003cli\u003e19 Inflammatory and Vascular Lesions (p.479)\u003c\/li\u003e\n  \u003cli\u003e20 Hyperplastic and Neoplastic Lesions (p.480)\u003c\/li\u003e\n  \u003cli\u003e21 Toxicologic Lesions (p.481)\u003c\/li\u003e\n  \u003cli\u003e22 Thymus (p.481)\u003c\/li\u003e\n  \u003cli\u003e23 Normal Thymus (p.481)\u003c\/li\u003e\n  \u003cli\u003e24 Congenital Lesions (p.482)\u003c\/li\u003e\n  \u003cli\u003e25 Degenerative Lesions (p.482)\u003c\/li\u003e\n  \u003cli\u003e26 Inflammatory and Vascular Lesions (p.484)\u003c\/li\u003e\n  \u003cli\u003e27 Hyperplastic and Neoplastic Lesions (p.484)\u003c\/li\u003e\n  \u003cli\u003e28 Neoplasia (p.484)\u003c\/li\u003e\n  \u003cli\u003e29 Thymic Lymphoma (p.485)\u003c\/li\u003e\n  \u003cli\u003e30 Toxicologic Lesions (p.485)\u003c\/li\u003e\n  \u003cli\u003eReferences (p.487)\u003c\/li\u003e\n  \u003cli\u003e25 Bone Marrow (p.489)\u003c\/li\u003e\n  \u003cli\u003e1 Introduction (p.489)\u003c\/li\u003e\n  \u003cli\u003e2 Normal Bone Marrow (p.490)\u003c\/li\u003e\n  \u003cli\u003e3 Disturbances in Hematopoietic Cell Growth (p.496)\u003c\/li\u003e\n  \u003cli\u003e4 Alterations of Bone Marrow Stromal Cells (p.503)\u003c\/li\u003e\n  \u003cli\u003e5 Degenerative Changes (p.506)\u003c\/li\u003e\n  \u003cli\u003e6 Miscellaneous (p.509)\u003c\/li\u003e\n  \u003cli\u003e26 Ovary (p.515)\u003c\/li\u003e\n  \u003cli\u003e1 Introduction (p.515)\u003c\/li\u003e\n  \u003cli\u003e2 Normal Ovary (p.515)\u003c\/li\u003e\n  \u003cli\u003e3 Congenital Lesions (p.516)\u003c\/li\u003e\n  \u003cli\u003e4 Nonproliferative Lesions (p.516)\u003c\/li\u003e\n  \u003cli\u003e5 Hyperplastic and Neoplastic Lesions (p.520)\u003c\/li\u003e\n  \u003cli\u003e6 Toxicologic Lesions (p.523)\u003c\/li\u003e\n  \u003cli\u003e27 Oviduct, Uterus, and Vagina (p.529)\u003c\/li\u003e\n  \u003cli\u003e1 Introduction (p.529)\u003c\/li\u003e\n  \u003cli\u003e2 Normal Tubular Genital Organs (p.529)\u003c\/li\u003e\n  \u003cli\u003e3 Congenital Lesions (p.532)\u003c\/li\u003e\n  \u003cli\u003e4 Aging Lesions (p.533)\u003c\/li\u003e\n  \u003cli\u003e5 Inflammatory and Vascular Lesions (p.533)\u003c\/li\u003e\n  \u003cli\u003e6 Nonproliferative Lesions (p.533)\u003c\/li\u003e\n  \u003cli\u003e7 Hyperplastic and Neoplastic Lesions (p.535)\u003c\/li\u003e\n  \u003cli\u003e8 Toxicologic Lesions (p.544)\u003c\/li\u003e\n  \u003cli\u003e28 Testis and Epididymis (p.553)\u003c\/li\u003e\n  \u003cli\u003e1 Introduction (p.553)\u003c\/li\u003e\n  \u003cli\u003e2 Normal Testis and Epididymis (p.553)\u003c\/li\u003e\n  \u003cli\u003e3 Congenital Lesions (p.558)\u003c\/li\u003e\n  \u003cli\u003e4 Degenerative Lesions (p.558)\u003c\/li\u003e\n  \u003cli\u003e5 Inflammatory and Vascular Lesions (p.559)\u003c\/li\u003e\n  \u003cli\u003e6 Hyperplastic and Neoplastic Lesions (p.560)\u003c\/li\u003e\n  \u003cli\u003e7 Miscellaneous (p.562)\u003c\/li\u003e\n  \u003cli\u003e8 Toxicologic Lesions (p.562)\u003c\/li\u003e\n  \u003cli\u003e29 Male Accessory Sex Glands (p.569)\u003c\/li\u003e\n  \u003cli\u003e1 Introduction (p.569)\u003c\/li\u003e\n  \u003cli\u003e2 Normal Male Sex Glands and Organs (p.569)\u003c\/li\u003e\n  \u003cli\u003e3 Congenital Lesions (p.574)\u003c\/li\u003e\n  \u003cli\u003e4 Degenerative Lesions (p.574)\u003c\/li\u003e\n  \u003cli\u003e5 Inflammatory and Vascular Lesions (p.574)\u003c\/li\u003e\n  \u003cli\u003e6 Hyperplastic and Neoplastic Lesions (p.574)\u003c\/li\u003e\n  \u003cli\u003e7 Toxicologic Lesions (p.575)\u003c\/li\u003e\n  \u003cli\u003e30 Cardiovascular System (p.579)\u003c\/li\u003e\n  \u003cli\u003e1 Introduction (p.579)\u003c\/li\u003e\n  \u003cli\u003e2 Congenital Lesions (p.581)\u003c\/li\u003e\n  \u003cli\u003e3 Degenerative Lesions (p.582)\u003c\/li\u003e\n  \u003cli\u003e4 Inflammatory Lesions (p.585)\u003c\/li\u003e\n  \u003cli\u003e5 Hyperplastic Lesions (p.587)\u003c\/li\u003e\n  \u003cli\u003e6 Neoplastic Lesions (p.588)\u003c\/li\u003e\n  \u003cli\u003e7 Toxicologic Lesions (p.591)\u003c\/li\u003e\n  \u003cli\u003e8 Induced Lesions In Blood Vessels (p.600)\u003c\/li\u003e\n  \u003cli\u003e31 Pituitary Gland (p.617)\u003c\/li\u003e\n  \u003cli\u003e1 Introduction (p.617)\u003c\/li\u003e\n  \u003cli\u003e2 Normal Pituitary Gland (p.617)\u003c\/li\u003e\n  \u003cli\u003e3 Congenital Lesions (p.621)\u003c\/li\u003e\n  \u003cli\u003e4 Degenerative Lesions (p.622)\u003c\/li\u003e\n  \u003cli\u003e5 Inflammatory and Vascular Lesions (p.624)\u003c\/li\u003e\n  \u003cli\u003e6 Hyperplastic and Neoplastic Lesions (p.624)\u003c\/li\u003e\n  \u003cli\u003e7 Miscellaneous Lesions (p.630)\u003c\/li\u003e\n  \u003cli\u003e8 Toxicologic Lesions (p.631)\u003c\/li\u003e\n  \u003cli\u003e32 Adrenal Gland (p.635)\u003c\/li\u003e\n  \u003cli\u003e1 Introduction (p.635)\u003c\/li\u003e\n  \u003cli\u003e2 Normal Adrenal Gland (p.635)\u003c\/li\u003e\n  \u003cli\u003e3 Congenital Lesions (p.638)\u003c\/li\u003e\n  \u003cli\u003e4 Degenerative Lesions (p.639)\u003c\/li\u003e\n  \u003cli\u003e5 Inflammatory and Vascular Lesions (p.641)\u003c\/li\u003e\n  \u003cli\u003e6 Hyperplastic and Neoplastic Lesions (p.641)\u003c\/li\u003e\n  \u003cli\u003e7 Miscellaneous Lesions (p.650)\u003c\/li\u003e\n  \u003cli\u003e8 Toxicologic Lesions (p.650)\u003c\/li\u003e\n  \u003cli\u003e33 Thyroid Gland (p.655)\u003c\/li\u003e\n  \u003cli\u003e1 Introduction (p.655)\u003c\/li\u003e\n  \u003cli\u003e2 Normal Thyroid Gland (p.655)\u003c\/li\u003e\n  \u003cli\u003e3 Congenital Anomalies (p.658)\u003c\/li\u003e\n  \u003cli\u003e4 Degenerative Lesions (p.659)\u003c\/li\u003e\n  \u003cli\u003e5 Inflammatory and Vascular Lesions (p.659)\u003c\/li\u003e\n  \u003cli\u003e6 Hyperplastic and Neoplastic Lesions (p.660)\u003c\/li\u003e\n  \u003cli\u003e7 Miscellaneous Lesions (p.669)\u003c\/li\u003e\n  \u003cli\u003e8 Toxicologic Lesions (p.669)\u003c\/li\u003e\n  \u003cli\u003eReferences (p.670)\u003c\/li\u003e\n  \u003cli\u003e34 Parathyroid Gland (p.673)\u003c\/li\u003e\n  \u003cli\u003e1 Introduction (p.673)\u003c\/li\u003e\n  \u003cli\u003e2 Normal Parathyroid Gland (p.673)\u003c\/li\u003e\n  \u003cli\u003e3 Congenital Lesions (p.674)\u003c\/li\u003e\n  \u003cli\u003e4 Degenerative Lesions (p.674)\u003c\/li\u003e\n  \u003cli\u003e5 Inflammatory and Vascular Lesions (p.675)\u003c\/li\u003e\n  \u003cli\u003e6 Hyperplasia and Neoplastic Lesions (p.675)\u003c\/li\u003e\n  \u003cli\u003e7 Miscellaneous (p.678)\u003c\/li\u003e\n  \u003cli\u003e8 Toxicologic Lesions (p.678)\u003c\/li\u003e\n  \u003cli\u003e35 Endocrine Pancreas (p.681)\u003c\/li\u003e\n  \u003cli\u003e1 Introduction (p.681)\u003c\/li\u003e\n  \u003cli\u003e2 Normal Endocrine Pancreas (p.681)\u003c\/li\u003e\n  \u003cli\u003e3 Congenital Lesions (p.683)\u003c\/li\u003e\n  \u003cli\u003e4 Degenerative Lesions (p.683)\u003c\/li\u003e\n  \u003cli\u003e5 Inflammatory and Vascular Lesions (p.684)\u003c\/li\u003e\n  \u003cli\u003e6 Hyperplastic and Neoplastic Lesions (p.684)\u003c\/li\u003e\n  \u003cli\u003e7 Hepatocyte Metaplasia (p.687)\u003c\/li\u003e\n  \u003cli\u003e8 Toxicologic Lesions (p.688)\u003c\/li\u003e\n  \u003cli\u003eIndex (p.691)\u003c\/li\u003e\n  \u003cli\u003e\u003cem\u003e... and 55 more chapters\u003c\/em\u003e\u003c\/li\u003e\n\u003c\/ul\u003e\n\n\n\u003cdiv style=\"margin:20px 0;\"\u003e\n\u003ch3\u003ePreview This Book (First 20 Pages)\u003c\/h3\u003e\n\n\u003cp style=\"font-size:12px;color:#666;margin-top:4px;\"\u003eScroll through the preview above to see the first 20 pages of this book.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cp\u003e\u003cstrong\u003e🔗 Download Link:\u003c\/strong\u003e \u003c\/p\u003e","brand":"Global Vet \u0026 Co","offers":[{"title":"Default Title","offer_id":51248803086651,"sku":null,"price":200.0,"currency_code":"HKD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0948\/3062\/5083\/files\/color-atlas-of-the-horse-8217-s-foot-pdf_HD.jpg?v=1780513721","url":"https:\/\/globalvetco.com\/products\/color-atlas-of-the-horse-8217-s-foot-pdf","provider":"Global Vet \u0026 Co Ltd","version":"1.0","type":"link"}